JPRN-UMIN000042731尚未招募未知
Prognostic factors for patients with anti-melanoma differentiation-associated gene 5 (MDA-5) antibody positive idiopathic inflammatory myopathy (IIM) associated interstitial lung disease (ILD): a single centor retrospective cohort study - Not applicable
Showa University Division of Rheumatology, Department of Medicine0 个研究点目标入组 30 人开始时间: 2020年12月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Not applicable
研究者
相似试验
已完成
不适用
Prognostic Factors for treatment and follow-up of patients after colorectal surgerychemo- en radiotherapeutische voorbehandelingseffecten op maagdarm neoplasmatagut cancer1001799110017998colorectal cancerNL-OMON31685Atrium Medisch Centrum400
招募中
不适用
Prognostic models and biomarkers in patients with acute decompensated heart failure admitted to wardacute decompensated heart failureacute heart failure10019280NL-OMON46619Catharina-ziekenhuis278
尚未招募
不适用
Heart failure on wardHeart failureNL-OMON27799Eigen geïnitieerd onderzoek278
尚未招募
不适用
Clinical study on prognostic factors in patients with neck paiWhiplash associated disorders, non-specific neck painJPRN-UMIN000037718Morinaga orthopedic clinic, Medical Corporation340
已完成
不适用
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma,topotecan,induction therapy,treatment response,prognostic factor,treatment-related toxicityTCTR20190602002Phramongkutklao Hospital and College of Medicine107